PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model

被引:0
作者
Weihua Li
Gang Niu
Lixin Lang
Ning Guo
Ying Ma
Dale O. Kiesewetter
Joseph M. Backer
Baozhong Shen
Xiaoyuan Chen
机构
[1] Harbin Medical University,Department of Medical Imaging and Nuclear Medicine, Fourth Affiliated Hospital
[2] National Institutes of Health (NIH),Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB)
[3] SibTech Inc.,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词
PET; [; F]FBEM-cEGF; HNSCC; EGFR;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:300 / 308
页数:8
相关论文
共 198 条
[1]  
Yarden Y(2001)Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 127-137
[2]  
Sliwkowski MX(2008)Multimodality imaging of the HER-kinase axis in cancer Eur J Nucl Med Mol Imaging 35 186-208
[3]  
Cai W(2006)Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas J Clin Oncol 24 4170-4176
[4]  
Niu G(2004)Targeting the HER-kinase axis in cancer Semin Oncol 31 9-20
[5]  
Chen X(2010)Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck Head Neck 32 1412-1421
[6]  
Chung CH(2006)Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 567-578
[7]  
Ely K(2008)Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 1116-1127
[8]  
McGavran L(2006)Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma Ann Oncol 17 450-456
[9]  
Varella-Garcia M(2007)Panitumumab the first fully human monoclonal antibody: from the bench to the clinic Anticancer Drugs 18 7-15
[10]  
Parker J(2004)Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 337-345